GORE® VIABIL®
4Pages

{{requestButtons}}

Catalog excerpts

GORE® VIABIL® - 1

LITERATURE SUMMARY Migration Summary for GORE® VIABIL® Biliary Endoprosthesis and BOSTON SCIENTIFIC WALLFLEX Biliary RX Fully Covered Stent

Open the catalog to page 1
GORE® VIABIL® - 2

Bezzi M, Zolovkins A, Cantisani V, etal. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction. Journal of Vascular & Interventional Radiology 2002;13(6):581-589. (n=24) Fanelli F, Orgera G, Bezzi M, Rossi P, Allegritti M, Passariello R. Management of malignant biliary obstruction: Technical and clinical results using an expanded polytetrafluoroethylene fluorinated ethylene propylene (ePTFE/FEP)-covered metallic stent after 6-year experience. European Radiology 2008;18(5):911-919. (n=77) Hatzidakis A, Krokidis M, Kalbakis K, Romanos J, Petrakis I,...

Open the catalog to page 2
GORE® VIABIL® - 3

GORE® VIABIL® Biliary Endoprosthesis MIGRATION RATE COMPARISON Based on 23 papers published from 2002 to 2015. 0.0% Bezzi M et al. 0.0% Fanelli F et al. 0.0% Hatzidakis A et al. 0.0% Krokidis M et al. 0.0% Irurzun J et al. 0.0% Krokidis M et al. 0.0% Marzio A et al. 0.0% Scheer F et al. 0.0% Schoder M et al. 0.0% Van Steenbergen W 0.0% Zurstrassen CE et al. GORE® VIABIL® Biliary Endoprosthesis migration rates of 0 to 1.4% outperform BOSTON SCIENTIFIC WALLFLEX Biliary RX Fully Covered Stent migration rates of 0 to 13%.

Open the catalog to page 3
GORE® VIABIL® - 4

W. L. Gore & Associates, Inc. Flagstaff, AZ 86004 +65.67332882 (Asia Pacific) 800.437.8181 (United States) 00800.6334.4673 (Europe) 928.779.2771 (United States) Products listed may not be available in all markets. WALLFLEX is a trademark of Boston Scientific Corporation GORE®, VIABIL®, and designs are trademarks of W. L. Gore & Associates. © 2017 W. L. Gore & Associates, Inc. AW0010-EN3 APRIL 2017

Open the catalog to page 4

All Gore catalogs and technical brochures

  1. Introducing

    4 Pages

  2. Endovascular

    28 Pages

  3. GORE-TEX®

    4 Pages